Copyright 2009-2012 BioSignia┬«, All Rights Reserved   

     

   

CORE TECHNOLOGY


Although the implications of many health risks such smoking, high cholesterol, and obesity have long been understood, the cumulative effect of multiple risks has not. BioSignia's flagship technology, Synthesis AnalysisTM, is a patented statistical method for summarizing the epidemiological association of the underlying contributing factors of multifactor diseases from disparate medical literature into comprehensive prediction models. In fact, this method is capable of summarizing virtually the entire body of evidence on epidemiological factors correlated with the onset of slowly developing multifactor diseases such as cardiovascular disease, diabetes, cancer, arthritis, and other serious chronic illnesses.


Synthesis Analysis is:

  • validated in conjunction with Duke University and the University of Washington

  • peer-reviewed; white papers available upon request

  • evergreen; allows for incorporation of new risk factors faster than conventional methods

 

 


For more information about our applied technologies, please visit BioSignia's dedicated web sites.
 
 
 



 
 
 



BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627